| ²é¿´: 363 | »Ø¸´: 0 | |||
qgaoamtfÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
|
[½»Á÷]
¡¾·ÖÏí¡¿Ö²Îï´ÙÉú³¤Î¢ÉúÎïÓëÈËÀಡÔÌå¾ßÓÐÏàÍ¬ÌØÕ÷
|
|
ÃÀ¹úBrookhaven¹ú¼ÒʵÑéÊÒ¡¢°®¶ûÀ¼¿Æ¿Ë´óѧºÍ°ÂµØÀûGraz¼¼Êõ´óѧµÄ¿ÆÑ§¼Ò·¢ÏÖ£¬Ö²ÎïÖг£¼ûµÄÒ»ÖÖϸ¾úºÍijÖÖסԺ»¼Õß»ú»áÐÔ¸ÐȾÏà¹ØÏ¸¾úÖ®¼ä´æÔÚ¼«´óµÄÏàËÆÖ®´¦¡£¿ÆÑ§¼Ò³ÆÕâÒ»·¢ÏÖ¶ÔÉúÎï¼¼Êõ¾ßÓÐÖØÒªÓ°Ï죬ÒòΪÕâÖÖÖ²Îïϸ¾úÔÚһϵÁÐÉúÎï¼¼ÊõÖб»Ó¦ÓᣠDaniel van der Lelie¼°ÆäͬʶÔÁ½ÖÖStenotrophomonas maltophiliaϸ¾ú½øÐÐÁ˶Աȡ£Stenotrophomonasϸ¾ú¾ßÓжàÖÖ¹¦ÄÜ£¬²¢ÇÒÄÜÊÊÓ¦²»Í¬µÄ»·¾³¡£Ä³Ð©¾úÖÖÄܵ¼ÖÂѪҺºÍ·Î²¿¸ÐȾ£¬¶øÁíһЩÔòÄÜ´Ù½øÖ²ÎïÉú³¤¡£Ñо¿ÈËÔ±¼ø¶¨³öÄÜʹÁ½ÖÖϸ¾ú¶ÔÖî¶à¿¹ÉúËØ²úÉú¿¹ÐԵĻùÒò¡£¾Ývan der Lelie³Æ£¬Õâ±íÃ÷¿¹ÉúËØ¿¹ÐÔÊǸÃÀàϸ¾úºË»ùÒò×éµÄÒ»²¿·Ö£¬¶ø²¢·ÇÒ½ÔºÖÐÄÇÖÖϸ¾úµÄÌØÓÐÐÔ×´¡£Ëû¾¯¸æËµ£¬¾¡¹ÜStenotrophomonasÒѾ±íÏÖÁËÒ»¶¨µÄDZÁ¦£¬±ÈÈç´Ù½øÖ²ÎïÉú³¤¡¢±£»¤Ö²ÎïÃâÊܲ¡ÔÌåÇÖÏ®ÒÔ¼°Éú²úµ°°×Ò©ÎïºÍøµÈ£¬µ«ÔÚÉúÎï¼¼ÊõÖÐÐè½÷É÷Ó¦ÓÃÕâÖÖϸ¾ú¡££¨×ªÌû×Ô£ºÉúÎï¹ÈBioon.com£¬2009-7-28£© ÉúÎï¹ÈÍÆ¼öÔʼ³ö´¦£º Nature Reviews Microbiology 7, 514-525 (July 2009) | doi:10.1038/nrmicro2163 The versatility and adaptation of bacteria from the genus Stenotrophomonas Robert P. Ryan1, Sebastien Monchy2, Massimiliano Cardinale3, Safiyh Taghavi2, Lisa Crossman4, Matthew B. Avison5, Gabriele Berg3, Daniel van der Lelie2 & J. Maxwell Dow2 The genus Stenotrophomonas comprises at least eight species. These bacteria are found throughout the environment, particularly in close association with plants. Strains of the most predominant species, Stenotrophomonas maltophilia, have an extraordinary range of activities that include beneficial effects for plant growth and health, the breakdown of natural and man-made pollutants that are central to bioremediation and phytoremediation strategies and the production of biomolecules of economic value, as well as detrimental effects, such as multidrug resistance, in human pathogenic strains. Here, we discuss the versatility of the bacteria in the genus Stenotrophomonas and the insight that comparative genomic analysis of clinical and endophytic isolates of S. maltophilia has brought to our understanding of the adaptation of this genus to various niches. 1 BIOMERIT Research Centre, Department of Microbiology, BioSciences Institute, University College Cork, Cork, Ireland. 2 Brookhaven National Laboratory, Biology Department, Upton, New York 11973-5000, USA. 3 Institute for Environmental Biotechnology, Graz University of Technology, Graz, Austria. 4 Pathogen Sequencing Unit, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. 5 Department of Cellular and Molecular Medicine, University of Bristol, School of Medical Sciences, University Walk, Bristol, BS8 1TD, UK. http://www.51xuewen.com/group/1952/topic_23078.htm |
» ²ÂÄãϲ»¶
±¾9 Ò»Ö¾Ô¸Î÷¹¤´ó085601 324Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸¶«±±´óѧ¿ØÖƹ¤³Ì085406Êý¶þÓ¢¶þ385£¬Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
272·Ö²ÄÁÏ×ÓÇóµ÷¼Á
ÒѾÓÐ22È˻ظ´
0856ר˶Çóµ÷¼Á Ï£ÍûÊÇaÇøÔºÐ£
ÒѾÓÐ23È˻ظ´
346£¬¹¤¿Æ0854Çóµ÷¼Á£¬×¨Ë¶
ÒѾÓÐ5È˻ظ´
337Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
266Çóµ÷¼Á
ÒѾÓÐ29È˻ظ´
309Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
Ò»Ö¾Ô¸0703»¯Ñ§ÕÐ61×îÖÕÅÅÃû62»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ28È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
ÕÒµ½Ò»Ð©Ïà¹ØµÄ¾«»ªÌû×Ó£¬Ï£ÍûÓÐÓÃŶ~
°²ê³¹ÜÀïÃæµÄ¾úµÚ¶þ´Î´ò¿ª£¬ÈÜÓÚÎÞ¾úË®³ÊÏÖÐõ×´
ÒѾÓÐ6È˻ظ´
¹ØÓÚÊɾúÌåÇÖȾϸ¾ú
ÒѾÓÐ17È˻ظ´
·¢½Í²úÎïHPLC½á¹û·ÖÎö
ÒѾÓÐ12È˻ظ´
¿Ý²ÝÑ¿æß¸Ë¾úæß×ÓÔÚÎÞ»úbufferÀï¿ÉÒÔÃÈ·¢Âð£¿
ÒѾÓÐ8È˻ظ´
´ó³¦¸Ë¾úµç¾µÊµÑé
ÒѾÓÐ9È˻ظ´
¼±¼±¼±¡¡ÎÒÃÇÉú»îÖг£Ê³ÓÃÖÖ×Ó£¬È绨ÉúÃ×£¬¿û¹Ï×Ó¶¼ÊÇÖÖ×Ó¡¡Õâ¾ä»°µ½µ×ÓÐûÓдí
ÒѾÓÐ29È˻ظ´
ÇóÖú¸öÀ§ÈźܾõÄÎÊÌ⣬±´ÀàµÄ·±ÑÜ£¿
ÒѾÓÐ7È˻ظ´
Öîλ΢ÉúÎï´óÏÀ£¬ÍøÉÏÂôµÄËáÄÌ·Ûµ½µ×°²²»°²È«°¡£¿Ð»Ð»£¡£¡£¡£¡£¡
ÒѾÓÐ19È˻ظ´
·¢½Í¹Þ¶¯» ¡ª½Ìѧ¶¯»
ÒѾÓÐ405È˻ظ´
ϸ¾úÒºÌåÅàÑø³¤³öСÇò
ÒѾÓÐ8È˻ظ´
ʵÑéÖÐΪÁ˲â΢ÉúÎïµÄÉú³¤Çé¿ö£¬ÈçºÎ¼ì²â£¿
ÒѾÓÐ22È˻ظ´
ÎÊÎʸ÷λ¸ßÊÖ£ºÊ²Ã´¾úÖеÄʲôµ°°×¿ÉÒÔ´Ù½øÖ²ÎïÉú³¤»ò¾ßÓп¹²¡ÐÔ
ÒѾÓÐ4È˻ظ´
ϸ¾úÉú³¤ÇúÏ߲ⶨ
ÒѾÓÐ24È˻ظ´
M9 Éú³¤ÅàÑø»ù·ÅÖÃÒ»Ììºó³öÏÖ³ÁµíÊÇÔõô»ØÊ£¿
ÒѾÓÐ9È˻ظ´
Çë¸ßÈËÖ¸µã£ºÕâЩֲÎïµÄÃû³Æ
ÒѾÓÐ5È˻ظ´
¿ÆÑдÓСľ³æ¿ªÊ¼£¬ÈËÈËΪÎÒ£¬ÎÒΪÈËÈË













»Ø¸´´ËÂ¥
µã»÷ÕâÀïËÑË÷¸ü¶àÏà¹Ø×ÊÔ´